ACCESSION: MSBNK-SMB_Measured-HSA001P0183009
RECORD_TITLE: Uncharacterized; LC-ESI-QFT; MS2; POSITIVE; Averaged data
DATE: 2025.04.02 (Averaged 2025.02.14, Processed 2025.02.21, Annotated 2025.04.02, Curated 2025.04.02)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Shin-MassBank project in preparation
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: REPOSITORY MB-POST
COMMENT: DATASET_ID MPST000004
COMMENT: DATASET_TITLE Annotation of various metabolites in SRM 1950 human serum
COMMENT: DATASET_AUTHORS Masatomo Takahashi, Yoshihiro Izumi, Kyushu University
COMMENT: MS1_M/Z_AVERAGED_THRES 0.750
COMMENT: MS2_M/Z_AVERAGED_THRES 4.000
COMMENT: DATASET_FILE_NUM 22
COMMENT: NUM_AVERAGED_SPEC 14
COMMENT: RAW_SPEC {'16_posi_2435': {'bp': 455740.0, 'sum': 1157937.0}, '1_posi_2371': {'bp': 438878.0, 'sum': 1118020.0}, '7_posi_2393': {'bp': 423022.0, 'sum': 1103320.0}, '3_posi_2412': {'bp': 421314.0, 'sum': 1126871.0}, '4_posi_2412': {'bp': 419638.0, 'sum': 1085560.0}, 'BLK02_2391': {'bp': 397318.0, 'sum': 1111899.0}, '17_posi_2434': {'bp': 380588.0, 'sum': 1019834.0}, '14_posi_2435': {'bp': 379071.0, 'sum': 971773.0}, '18_posi_2476': {'bp': 373656.0, 'sum': 1025033.0}, '10_posi_2477': {'bp': 322412.0, 'sum': 949610.0}, '2_posi_2455': {'bp': 310836.0, 'sum': 846681.0}, '13_posi_2477': {'bp': 307833.0, 'sum': 837504.0}, '5_posi_2433': {'bp': 306335.0, 'sum': 850017.0}, '11_posi_2496': {'bp': 247233.0, 'sum': 689773.0}}
COMMENT: RETENTION_TIME_STDEV 0.075
COMMENT: PRECURSOR_M/Z_RAW 183.123741
COMMENT: PRECURSOR_M/Z_STDEV 0.000060
COMMENT: PRECURSOR_IN_MS1 mz 183.124054; int 26.843; delta(ppm) 1.034181
COMMENT: PROPOSED_CHARGE_STATE +1; mz 184.127224; int 2.269; cor 0.827
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_ION_FORM M+H; M+CH3OH+H; mz 215.150275; int 7.181; cor 0.811
COMMENT: PROPOSED_ION_FORM M+H; M+ACN+H; mz 224.150624; int 5.353; cor 0.833
COMMENT: PROPOSED_ION_FORM M+Na; M+ACN+Na; mz 224.150624; int 5.353; cor 0.833
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+H; mz 142.097532; int 167.340; cor 0.692
COMMENT: PROPOSED_ION_FORM M+ACN+H; M+2ACN+H; mz 224.150624; int 5.353; cor 0.833
COMMENT: PROPOSED_ION_FORM M+ACN+Na; M+Na; mz 142.097532; int 167.340; cor 0.692
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+H; mz 101.070965; int 28.795; cor 0.833
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+NH4; mz 118.097387; int 1.077; cor 0.644
COMMENT: PROPOSED_ION_FORM M+2ACN+H; M+ACN+H; mz 142.097532; int 167.340; cor 0.692
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.093; C8H14N4O; [M+H]+; delta(ppm) 0.093347
COMMENT: PROPOSED_MF SevenGoldenRules 0.135; C6H11N3O; [M+ACN+H]+; delta(ppm) 0.134666
COMMENT: PROPOSED_MF SevenGoldenRules 0.210; C4H8N2O; [M+2ACN+H]+; delta(ppm) 0.209866
COMMENT: PROPOSED_MF MS-FINDER 3.495; C6H11N3O; [M+ACN+H]+; delta(ppm) 89372.048184
COMMENT: PROPOSED_MF MS-FINDER 3.309; C8H14N4O; [M+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF MS-FINDER 3.267; C4H8N2O; [M+2ACN+H]+; delta(ppm) 441081.848281
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.797; C8H14N4O; [M+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS5_Sirius 13.797; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS5_Sirius 12.518; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.535; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.535; C8H14N4O; [M+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Sirius 22.535; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Sirius 16.939; C5H15FN4O2; [M+H]+; delta(ppm) -6.149804
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.380; C4H9N6; [M+C2H3N+H]+; delta(ppm) 7.421983
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.380; C6H12N7; [M+H]+; delta(ppm) 7.421983
COMMENT: PROPOSED_MF SIRIUS6_Sirius 5.380; C2H6N5; [M+C4H6N2+H]+; delta(ppm) 7.421983
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.214; C6H15O2; [M+C2H3N+Na]+; delta(ppm) 51613.453593
COMMENT: PROPOSED_MF SIRIUS6_Sirius 3.214; C8H18NO2; [M+Na]+; delta(ppm) 51613.453593
COMMENT: PROPOSED_MF SIRIUS6_Sirius 0.951; C4H17N5OP; [M+H]+; delta(ppm) -1.598003
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.006; C8H13O2; [M+C2H3N+H]+; delta(ppm) -7.241998
COMMENT: PROPOSED_MF SIRIUS6_Sirius -0.006; C10H16NO2; [M+H]+; delta(ppm) -7.241998
COMMENT: PROPOSED_MF SIRIUS6_Sirius -2.739; C8H15F3N; [M+H]+; delta(ppm) 6.111098
COMMENT: PROPOSED_MF SIRIUS6_Sirius -7.365; C2H15N8P; [M+H]+; delta(ppm) 5.734017
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H11N3O; [M+C2H3N+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C6H15O2; [M+C2H3N+Na]+; delta(ppm) 51613.453593
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H18NO2; [M+Na]+; delta(ppm) 51613.453593
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C8H14N4O; [M+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C4H8N2O; [M+C4H6N2+H]+; delta(ppm) 0.089938
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.585; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; N=1OC(=NC1C)C2N(C)CC(N)C2
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.340; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; CC(C)(C)C1=CC(=NN1)C(=O)NN
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.325; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; NCCC(=O)NCCC1=CN=CN1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.313; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; CCCC1=NN(C)C(C(N)=O)=C1N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.258; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; NC(CCC1=CN=CN1)CC(O)=N
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.797; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.524; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.360; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.245; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.234; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.218; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.100; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.005; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.954; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 4.932; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; L-Histidinol
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; IMAGWKUTFZRWSB-HYXAFXHYSA-N; [M+2ACN+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.744; MIWXKXSYVQATIB-UHFFFAOYSA-N; [M+H]+; CNP0438350
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.708; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.704; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; perhydropyrimidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.490; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-1-methyl-3-propylpyrazole-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.444; CNQSLMMJABEBDE-UHFFFAOYNA-N; [M+H]+; 3-amino-5-(1H-imidazol-5-yl)pentanamide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.030; ZJFRMJHBYDBUGG-UHFFFAOYSA-N; [M+H]+; 5-tert-butyl-1H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.000; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; N-Nitroso-pyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 4.000; ANRUJJLGVODXIK-UHFFFAOYSA-N; [M+H]+; 3-amino-N-[2-(1H-imidazol-5-yl)ethyl]propanamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.708; ZQISRDCJNBUVMM-YFKPBYRVSA-N; [M+ACN+H]+; (2S)-2-amino-3-(1H-imidazol-5-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 2.033; WNYADZVDBIBLJJ-UHFFFAOYSA-N; [M+2ACN+H]+; 1-nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.782; IWELDVXSEVIIGI-UHFFFAOYSA-N; [M+2ACN+H]+; piperazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.673; IMAGWKUTFZRWSB-HWKANZROSA-N; [M+2ACN+H]+; N-[(E)-ethylideneamino]-N-methylformamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.570; NQPJDJVGBDHCAD-UHFFFAOYSA-N; [M+2ACN+H]+; 1,3-diazinan-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.314; DJPLUEGVLBIDTL-UHFFFAOYSA-N; [M+H]+; 4-[2-(dimethylamino)ethoxy]pyrimidin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.243; AFGWGIRVJYUUMY-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.241; DWEQVNFWAKJCEY-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.231; SINFFOPRQUJXEU-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)pyrazol-3-yl]hydrazine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.226; KMUNXDCQPABTSC-UHFFFAOYSA-N; [M+H]+; N,4-diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.206; AKKYYGMQUOASSM-UHFFFAOYSA-N; [M+H]+; 5-methyl-N'-propan-2-yl-3H-pyrazole-3-carbohydrazide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.200; QYLRWTDPRQLHNV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyldiazirin-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.187; OXTSWTYFSHETKF-UHFFFAOYSA-N; [M+H]+; 4-amino-N,2-diethylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.186; NMGPZPUIAUQPJA-UHFFFAOYSA-N; [M+ACN+H]+; [1-(2-aminoethyl)imidazol-4-yl]methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.161; IVIGOAVSYQZAMR-UHFFFAOYSA-N; [M+H]+; 4-ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.160; PZMXDLWWQHYXGY-UHFFFAOYSA-N; [M+H]+; 4-amino-2-methyl-5-propylpyrazole-3-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.150; OCEJLBIKKZYCBH-UHFFFAOYSA-N; [M+ACN+H]+; 1-(azetidin-3-yl)imidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; IBYIOHMUWBIKCY-UHFFFAOYSA-N; [M+2ACN+H]+; N-methoxyazetidin-3-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.143; WBHVOQXHRCGQTP-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-ethyl-1,2,4-oxadiazol-5-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.130; USQBXXFEWJNNLW-UHFFFAOYSA-N; [M+H]+; 5-methyl-2-piperidin-4-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.124; RTGLANPQFMENLF-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,6,7,8,8a-hexahydro-1H-imidazo[1,5-a]pyrazin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.108; REYGCAPKUGCICS-UHFFFAOYSA-N; [M+ACN+H]+; N-[(3-methyl-1,2,4-oxadiazol-5-yl)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.098; CIECLHRLHFXCEF-UHFFFAOYSA-N; [M+H]+; 6-ethyl-4-(propan-2-ylamino)-1H-1,3,5-triazin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; VEBSQSGLZKTWDS-BQBZGAKWSA-N; [M+H]+; N-methyl-1-[(2R,3R)-3-(1H-1,2,4-triazol-5-yl)oxolan-2-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.095; VCSSOKBEBXXSDV-UHFFFAOYSA-N; [M+ACN+H]+; 5-methyl-2,5,7-triazaspiro[3.4]octan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.093; OTXQUUARRHAWEI-UHFFFAOYSA-N; [M+H]+; 5-(1-methylpiperidin-3-yl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.090; DZQDVYLUCQEKGH-UHFFFAOYSA-N; [M+H]+; 4-methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.087; RUOBZLJWEMZMRP-UHFFFAOYSA-N; [M+H]+; 2-(5-ethyl-1H-1,2,4-triazol-3-yl)morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.085; YUTDFIMDLUJOJK-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.076; IADZORFSCHBHIT-UHFFFAOYSA-N; [M+H]+; 3-methyl-4-(piperazin-1-ylmethyl)-1,2,5-oxadiazole
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; GNMSTEOVIGIVCR-UHFFFAOYSA-N; [M+H]+; 1-(2-methoxyethyl)-4,5,6,7-tetrahydrotriazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; NPNNXLZXOYJJIV-UHFFFAOYSA-N; [M+H]+; [1-(oxan-4-yl)triazol-4-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.066; OZVXTNDTEWDMGH-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.060; QEHBKIRYKVJAAQ-UHFFFAOYSA-N; [M+H]+; (1-piperidin-3-yltriazol-4-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.056; APLFLTVZOUDTFG-UHFFFAOYSA-N; [M+H]+; 2-methyl-5-(oxan-4-yl)-1,2,4-triazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.050; ZIWIZUNXJJKHPT-UHFFFAOYSA-N; [M+H]+; 3-(triazol-1-ylmethyl)piperidin-3-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.048; VCPRZYKEIPMTGJ-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-2-(1-methylpyrazol-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.037; JLNGHOSDXPAGAH-UHFFFAOYSA-N; [M+H]+; 4-(2-methyl-1,2,4-triazol-3-yl)piperidin-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.029; NTVMXTHTWWIQBG-RNFRBKRXSA-N; [M+H]+; [(2R,3R)-2-(3-methyl-1H-1,2,4-triazol-5-yl)oxolan-3-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.018; QKHNQZUVFSQKFD-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylpyrazol-4-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.014; YCXQDZIPLMEYGK-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(methylamino)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; OZGHNDLEHPCVJQ-UHFFFAOYSA-N; [M+ACN+H]+; 2-[4-(aminomethyl)pyrazol-1-yl]ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; CIZWSGSWDKEWQD-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.977; ZQIOGDSNYJYBTN-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-aminopyrazol-1-yl)propan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.969; QJCMYUTUCCCBMY-UHFFFAOYSA-N; [M+ACN+H]+; 1-(3-aminopyrazol-1-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.967; QSRIMEJLSVTOCT-UHFFFAOYSA-N; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.964; RYFSOJLJCKEYBP-UHFFFAOYSA-N; [M+ACN+H]+; 3-(1-aminoethyl)-1-methylpyrazol-4-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.963; KJTMKVRSTYLHQN-UHFFFAOYSA-N; [M+ACN+H]+; 5-(methoxymethyl)-1-methylpyrazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.962; DHXLEVPVBKFTTR-UHFFFAOYSA-N; [M+H]+; N,N-dimethyl-5-pyrrolidin-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.961; AJOFBNLXIBLIPM-UHFFFAOYSA-N; [M+ACN+H]+; 2-amino-1-(1-methylimidazol-2-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.957; AMRWCMHXSOIYPO-UHFFFAOYSA-N; [M+H]+; (5-piperidin-1-yl-1,3,4-oxadiazol-2-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.940; ASEMWMLOGSUFFL-UHFFFAOYSA-N; [M+ACN+H]+; 4-(2-aminoethyl)-3-methyl-1,4-dihydropyrazol-5-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.936; BIJFXVFSSOVINP-UHFFFAOYSA-N; [M+ACN+H]+; 1-(5-ethyl-1,2,4-oxadiazol-3-yl)-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.929; WRNALNJFNAAVKM-UHFFFAOYSA-N; [M+ACN+H]+; 2,5,7-triazaspiro[3.5]nonan-6-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.926; GTEXXCCAHDQARI-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-pyrazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.915; VQXSKHZPJBCSIZ-UHFFFAOYSA-N; [M+H]+; [3-(oxan-4-yl)-1H-1,2,4-triazol-5-yl]methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; YSSJLUSRTMOENN-UHFFFAOYSA-N; [M+H]+; 2-(methoxymethyl)-5,6,7,8-tetrahydro-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.908; KENWBTPXOITUBG-UHFFFAOYSA-N; [M+ACN+H]+; 3-(5-methyl-1,3,4-oxadiazol-2-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.906; IPLIJMUJLJBZDZ-UHFFFAOYSA-N; [M+ACN+H]+; 1-amino-3-imidazol-1-ylpropan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.905; LGPFTDILVKZMRC-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-amino-4-methylpyrazol-1-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.901; VUQAASCCQZTWOG-UHFFFAOYSA-N; [M+ACN+H]+; 5-butan-2-yl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.900; HKUSMMLJSPSXCL-UHFFFAOYSA-N; [M+ACN+H]+; 5-(3-aminopropyl)-1,2-dihydropyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.898; WWGWIEDOVSRZPU-UHFFFAOYSA-N; [M+ACN+H]+; 2-tert-butyl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.893; YEKKCMQUYOKDQD-UHFFFAOYSA-N; [M+ACN+H]+; 3-(3-methyl-1,2,4-oxadiazol-5-yl)propan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.883; IUBWCBLFKCGVGV-UHFFFAOYSA-N; [M+ACN+H]+; 2-(2-iminopyrrolidin-1-yl)acetamide
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.878; JANUDBLANRHSLI-UHFFFAOYSA-N; [M+ACN+H]+; 5-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.874; LHHBJUDYVRBYMB-UHFFFAOYSA-N; [M+ACN+H]+; 4-(aminomethyl)-2,5-dimethyl-1H-pyrazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.858; VAYGOKAONCMZCM-UHFFFAOYSA-N; [M+ACN+H]+; 5-tert-butyl-1,2,4-oxadiazol-3-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.857; YHUCZYONIXCWBX-VQVTYTSYSA-N; [M+H]+; (1S,2S,4R)-2-(aminomethyl)-4-(1H-1,2,4-triazol-5-yl)cyclopentan-1-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.854; WJYMBVJBSFMDLE-HWKANZROSA-N; [M+2ACN+H]+; (2E)-2-(dimethylhydrazinylidene)acetaldehyde
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.844; WONCYNYJYMAVNA-UHFFFAOYSA-N; [M+ACN+H]+; 5-tert-butyl-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.839; LEWKFFUYRKWKLV-UHFFFAOYSA-N; [M+ACN+H]+; 5-methyl-2-propan-2-yl-4H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.836; ILUUSWWGUOPVLO-UHFFFAOYSA-N; [M+ACN+H]+; 3-tert-butyl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.835; KGTZRGLLNSCJNH-UHFFFAOYSA-N; [M+ACN+H]+; 5-(2-methylpropyl)-1,3,4-oxadiazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.828; LURMHCWOXHNATM-UHFFFAOYSA-N; [M+ACN+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.813; XWBPAFFFOLTPTR-UHFFFAOYSA-N; [M+ACN+H]+; 3-(methoxymethyl)-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.809; YXAYZDNOWMFZLL-UHFFFAOYSA-N; [M+2ACN+H]+; 2-(3-methyldiazirin-3-yl)ethanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.808; VPOYXTRLFXNRJN-UHFFFAOYSA-N; [M+ACN+H]+; N-methyl-3-propan-2-yl-1,2,4-oxadiazol-5-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.806; ITDOBWWRWYKLQJ-UHFFFAOYSA-N; [M+ACN+H]+; 2,3,4,5-tetrahydropyridin-6-ylurea
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.805; FSRLLJVJCVKHQI-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-hydroxy-2-methylpropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.800; VQNRBFXKOWOEAC-UHFFFAOYSA-N; [M+ACN+H]+; 3-ethoxy-1-methylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; MGDACALOFCAYGF-UHFFFAOYSA-N; [M+ACN+H]+; (3-methoxy-1-methylpyrazol-4-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.797; RPGPPCHMKDWLRT-UHFFFAOYSA-N; [M+2ACN+H]+; 2-amino-3-methoxypropanenitrile
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; UXZYNPKVFMWVMT-UHFFFAOYSA-N; [M+ACN+H]+; 1-ethyl-3-methoxypyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; ZPUGMHPXVOHOAZ-UHFFFAOYSA-N; [M+ACN+H]+; (4-propyl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.796; XIAOMTCYUPNRKB-UHFFFAOYSA-N; [M+ACN+H]+; (2-propan-2-yl-1,2,4-triazol-3-yl)methanol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.795; YGJWTXRSKNXUAY-UHFFFAOYSA-N; [M+ACN+H]+; 5-methoxy-1,3-dimethylpyrazol-4-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.785; SRIBOFCAJXTSEL-UHFFFAOYSA-N; [M+ACN+H]+; 1-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.770; IZYJJPFDVHGKAG-UHFFFAOYSA-N; [M+ACN+H]+; 2-(1-methyltriazol-4-yl)propan-2-ol
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.760; JTPZTKBRUCILQD-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylimidazolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.715; AEBOLOPWWMZLBL-UHFFFAOYSA-N; [M+ACN+H]+; 2-(3-methyl-1,2,4-oxadiazol-5-yl)propan-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.712; VPVZSRIIAONGMU-UHFFFAOYSA-N; [M+2ACN+H]+; 5,6-dihydro-4H-1,3-oxazin-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.705; PIXPFRMNXPKTFS-UHFFFAOYSA-N; [M+2ACN+H]+; 4-methyl-4,5-dihydro-1,3-oxazol-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.702; GQVNTZNZAGYMPA-UHFFFAOYSA-N; [M+2ACN+H]+; N-methyl-1,3-oxazolidin-2-imine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; XGPRUICIGLRGSQ-UHFFFAOYSA-N; [M+ACN+H]+; (5-propan-2-yl-1,2,4-oxadiazol-3-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; JKZWEWZMYSBQME-UHFFFAOYSA-N; [M+2ACN+H]+; 1-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; WYVJDRGXWOXCCH-UHFFFAOYSA-N; [M+2ACN+H]+; 5-methylpyrazolidin-3-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.691; PEPBWGGISBCQDW-UHFFFAOYSA-N; [M+ACN+H]+; (3-propan-2-yl-1,2,4-oxadiazol-5-yl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.690; YNDAMDVOGKACTP-UHFFFAOYSA-N; [M+2ACN+H]+; 3-aminopyrrolidin-2-one
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.676; MHFBJJKCSNFJEO-UHFFFAOYSA-N; [M+2ACN+H]+; 4,5-dihydro-1,2-oxazol-3-ylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.170; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal mono-dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.482; IMAGWKUTFZRWSB; [M+C4H6N2+H]+; Ethylidene gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.715; JTPZTKBRUCILQD; [M+C4H6N2+H]+; 1-Methyl-2-imidazolidone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -173.710; IWELDVXSEVIIGI; [M+C4H6N2+H]+; piperazone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -174.369; WNYADZVDBIBLJJ; [M+C4H6N2+H]+; Nitrosopyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -177.964; ZJULPBMTEMGRNC; [M+C4H6N2+H]+; 2-Methoxyimidazoline
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -181.232; OWSNZTOUPZXKPJ; [M+C4H6N2+H]+; Methylallylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -183.573; NQPJDJVGBDHCAD; [M+C4H6N2+H]+; Propyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -187.449; AWDNCVJVQYZMTL; [M+C4H6N2+H]+; N-Methylethyleneurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -190.488; KAXILSKFDQXZPP; [M+C4H6N2+H]+; Vinylethylnitrosamin
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -192.905; KENWBTPXOITUBG; [M+C2H3N+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -197.655; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-Hem-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -198.970; YNDAMDVOGKACTP; [M+C4H6N2+H]+; Ambcb4019954
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -199.704; VPJDULFXCAQHRC; [M+C4H6N2+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.462; UAUSQEVPWPGBHG; [M+C4H6N2+H]+; 3-Aminocrotonamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -205.970; DWEQVNFWAKJCEY; [M+C4H6N2+H]+; 4-Methyl-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -206.822; IPLIJMUJLJBZDZ; [M+C2H3N+H]+; 3-amino-1-imidazolylpropan-2-ol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -208.859; KKCWBKUOPJMUQV; [M+C4H6N2+H]+; 2-azetidinecarboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -209.175; VPQRCGYRFWYOEO; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -220.708; UEUMMYRZUZKMRI; [M+C2H3N+H]+; Ambap52883-26-8
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -221.159; OMCUPXRCMTUDHI; [M+C4H6N2+H]+; Cyclopropanecarboxamidoxime
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -223.336; AFGWGIRVJYUUMY; [M+H]+; Ambcb5109422
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -225.648; DUCOZVHXTHIRIB; [M+C2H3N+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.055; CIZWSGSWDKEWQD; [M+C2H3N+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -232.172; WONCYNYJYMAVNA; [M+C2H3N+H]+; 2-Amino-5-tert-butyl-1,3,4-oxadiazol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -233.190; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -240.167; LURMHCWOXHNATM; [M+C2H3N+H]+; 1-(2-methoxyethyl)pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.086; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -241.242; PZMXDLWWQHYXGY; [M+H]+; Oprea1_583437
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -244.949; QSRIMEJLSVTOCT; [M+H]+; 4-[2-(1,2,4-triazol-1-yl)ethyl]morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -245.299; CLMGCKCDSPUQEE; [M+C4H6N2+H]+; cyclopropylurea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -246.965; ZHFKVNRMZIOKGZ; [M+C4H6N2+H]+; 2-Oxazolamine, 4,5-dihydro-5-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -249.333; ITDOBWWRWYKLQJ; [M+C2H3N+H]+; (2-Piperidylidene)urea
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -250.156; PIXPFRMNXPKTFS; [M+C4H6N2+H]+; 4-Methyl-oxazolidin-(2Z)-ylideneamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.594; YXAYZDNOWMFZLL; [M+C4H6N2+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -251.735; JFYKIEHOOZWARC; [M+C4H6N2+H]+; Oprea1_824763
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -252.622; IVIGOAVSYQZAMR; [M+H]+; 4-Ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -256.536; YDDAGKSURVEMCI; [M+C2H3N+H]+; Acetamide, 2-diazo-N,N-diethyl-
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -257.904; DZOWYKFQSIAYCW; [M+C4H6N2+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -266.094; DZQDVYLUCQEKGH; [M+H]+; 4-Methoxy-N-methyl-6-propyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -276.594; ZQISRDCJNBUVMM; [M+C2H3N+H]+; histidol
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -277.398; CIECLHRLHFXCEF; [M+H]+; 2-ethyl-6-(propan-2-ylamino)-1H-1,3,5-triazin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -283.028; DJPLUEGVLBIDTL; [M+H]+; 2-Amino-4-dimethylaminoethoxypyrimidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -288.964; YUTDFIMDLUJOJK; [M+C2H3N+H]+; N-methyl-1,6-diazabicyclo[3.1.0]hexane-5-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -303.313; APLFLTVZOUDTFG; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -306.631; DHXLEVPVBKFTTR; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -320.988; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butylpyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -328.974; CNQSLMMJABEBDE; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -398.565; MIWXKXSYVQATIB; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -490.225; AKKYYGMQUOASSM; [M+H]+; 1-(5-Methyl-3-pyrazolylcarbonyl)-2-isopropylhydrazine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.198; AFGWGIRVJYUUMY; [M+H]+; Ambcb5109422
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.190; KENWBTPXOITUBG; [M+C2H3N+H]+; [3-(5-methyl-1,3,4-oxadiazol-2-yl)propyl]amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.159; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal mono-dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -71.360; JTPZTKBRUCILQD; [M+C4H6N2+H]+; 1-(Methyl-d3)-2-imidazolidinone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -74.395; IMAGWKUTFZRWSB; [M+C4H6N2+H]+; Gyromitrin
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -88.476; KAXILSKFDQXZPP; [M+C4H6N2+H]+; Vinylethylnitrosamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.158; AWDNCVJVQYZMTL; [M+C4H6N2+H]+; 1-Aziridinecarboxamide, N-methyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -93.629; VPJDULFXCAQHRC; [M+C4H6N2+H]+; Allylurea
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -95.014; CWTDBXBAFSXFET; [M+C4H6N2+H]+; 3-Methylimidazolidin-4-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -98.037; OWSNZTOUPZXKPJ; [M+C4H6N2+H]+; N-Nitroso-N-methylallylamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -100.210; MFCHWYSOGVAXNC; [M+C4H6N2+H]+; N-methyl-N-(nitrosomethyl)ethenamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -113.393; WJYMBVJBSFMDLE; [M+C4H6N2+H]+; Glyoxal dimethylhydrazone
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -115.635; DZOWYKFQSIAYCW; [M+C4H6N2+H]+; 3,6-dihydro-2H-oxazin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -155.424; YDDAGKSURVEMCI; [M+C2H3N+H]+; (E)-2-(diethylamino)-2-hydroxyethenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -166.060; QSRIMEJLSVTOCT; [M+H]+; 4-(2-(1H-1,2,4-Triazol-1-yl)ethyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -173.885; REYGCAPKUGCICS; [M+C2H3N+H]+; N-[(3-Methyl-1,2,4-oxadiazol-5-YL)methyl]ethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -187.763; KMUNXDCQPABTSC; [M+H]+; N,4-Diethyl-6-methoxy-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -193.931; GNMSTEOVIGIVCR; [M+H]+; 1-(2-methoxyethyl)-1H,4H,5H,6H,7H-[1,2,3]triazolo[4,5-c]pyridine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -209.028; QIXFXNMDRJRTIJ; [M+C2H3N+H]+; 1-(2-Hydroxyethyl)-2-methyl-5-aminoimidazole
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -211.221; ANRUJJLGVODXIK; [M+H]+; Carcinine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -212.160; AFGWGIRVJYUUMY; [M+H]+; 4-Ethoxy-N-ethyl-6-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -218.390; UEUMMYRZUZKMRI; [M+C2H3N+H]+; 4,5-Diethyl-2,4-dihydro-3H-1,2,4-triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -224.034; LURMHCWOXHNATM; [M+C2H3N+H]+; 1-(2-methoxyethyl)-1H-pyrazol-4-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -226.133; CIZWSGSWDKEWQD; [M+C2H3N+H]+; 1-(2-methoxyethyl)-1H-pyrazol-3-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -231.611; ZPUGMHPXVOHOAZ; [M+C2H3N+H]+; (4-propyl-1H-1,2,4-triazol-4-ium-5-yl)methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -232.288; LEWKFFUYRKWKLV; [M+C2H3N+H]+; 2-Isopropyl-5-methyl-2,4-dihydro-[1,2,4]triazol-3-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -235.041; CIECLHRLHFXCEF; [M+H]+; 1,3,5-Triazin-2(1H)-one, 4-ethyl-6-((1-methylethyl)amino)-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -235.865; WWGWIEDOVSRZPU; [M+C2H3N+H]+; 1-tert-butyl-4,5-dihydro-1H-1,2,4-triazol-5-one
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -236.725; XIAOMTCYUPNRKB; [M+C2H3N+H]+; [1-(propan-2-yl)-1H-1,2,4-triazol-5-yl]methanol
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -253.872; DZQDVYLUCQEKGH; [M+H]+; 1,3,5-Triazin-2-amine, 4-methoxy-N-methyl-6-propyl-
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -255.176; NDFXVDCXWFVBHJ; [M+H]+; 5-amino-1-tert-butyl-1H-pyrazole-4-carboxamide
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -257.124; IVIGOAVSYQZAMR; [M+H]+; 4-Ethoxy-6-ethyl-N-methyl-1,3,5-triazin-2-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_CSI:biodatabase -265.345; YSSJLUSRTMOENN; [M+H]+; 2-(methoxymethyl)-5H,6H,7H,8H-[1,2,4]triazolo[1,5-a]pyridin-6-amine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.191; QSRIMEJLSVTOCT; [M+H]+; 4-(2-(1H-1,2,4-Triazol-1-yl)ethyl)morpholine
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.184; YDDAGKSURVEMCI; [M+C2H3N+H]+; (E)-2-(diethylamino)-2-hydroxyethenediazonium
COMMENT: PROPOSED_COMPOUND SIRIUS6_Confidence:biodatabase 0.129; JTPZTKBRUCILQD; [M+C4H6N2+H]+; 1-(Methyl-d3)-2-imidazolidinone
COMMENT: CONFIDENCE Level 5: Exact mass of interest 183.124054; Observed in MS1; Charge state +1;
CH$COMPOUND_CLASS: Uncharacterized
CH$FORMULA: C39H42O2
CH$EXACT_MASS: 542.318480
CH$SMILES: CCCC#Cc1cc(C#CCCC)cc(C#Cc2cc(C#CC(C)(C)C)c(cc2C#CC(C)(C)C)C2OCCO2)c1
CH$IUPAC: InChI=1S/C39H42O2/c1-9-11-13-15-30-25-31(16-14-12-10-2)27-32(26-30)17-18-33-28-35(20-22-39(6,7)8)36(37-40-23-24-41-37)29-34(33)19-21-38(3,4)5/h25-29,37H,9-12,23-24H2,1-8H3
CH$LINK: PUBCHEM CID:11353257
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Serum
AC$INSTRUMENT: Nexera X2 UHPLC system, Shimadzu - Q Exactive Orbitrap, Thermo Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY 20 V
AC$MASS_SPECTROMETRY: COLLISION_GAS N2
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 0.75; MS2(ppm) 4.00
AC$CHROMATOGRAPHY: COLUMN_NAME GL-HilicAex 2.1 x 150 mm, 5 mm (Resonac)
AC$CHROMATOGRAPHY: FLOW_GRADIENT B conc(%). 0 min: 95, 0.5 min: 95, 15.5 min: 40, 16.5 min: 0, 26.5 min: 0, 27.5 min: 95, 35 min: 95.
AC$CHROMATOGRAPHY: FLOW_RATE 0.4 mL/min
AC$CHROMATOGRAPHY: RETENTION_TIME 4.882
MS$FOCUSED_ION: PRECURSOR_M/Z 183.124054
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-001i-0900000000-91dcfe4020de8a305e7f
PK$ANNOTATION: m/z int annotation m/z_nocal m/z_std(ppm) int_std cor n
  69.0446351 28.9835 ? 69.045261 1.0428 6.47 0.5121 14
  71.0603668 45.4186 ? 71.060980 1.3932 8.57 0.3011 14
  72.0443492 48.5678 ? 72.044956 1.4991 7.50 0.6352 14
  85.0759529 22.0103 ? 85.076432 1.2695 5.67 0.5868 14
  87.0915931 16.9517 ? 87.092046 1.7797 3.05 0.7143 13
  97.0760608 15.0249 ? 97.076406 2.0911 4.85 0.3986 12
  98.9841093 27.6328 ? 98.984439 1.1416 7.50 -0.4022 14
  112.0870283 49.3659 ? 112.087233 1.4631 11.07 0.2835 14
  113.0709371 326.3136 ? 113.071131 0.3714 18.82 0.9385 14
  113.1072068 14.8432 ? 113.107400 1.5295 3.80 -0.1429 13
  115.0866046 202.1753 ? 115.086775 0.3563 35.94 0.7055 14
  123.0554377 14.6534 ? 123.055507 2.2023 3.67 0.1758 10
  124.0869528 50.4980 ? 124.087008 1.4587 9.84 0.2835 14
  125.0709255 17.3049 ? 125.070967 1.6231 4.53 0.2802 13
  127.0154078 22.0888 ? 127.015421 1.5274 9.03 -0.4769 14
  138.1025531 22.8668 ? 138.102459 1.4699 5.77 0.2352 14
  139.0866624 16.7402 ? 139.086567 1.6321 3.83 0.3091 11
  140.0818643 111.3355 ? 140.081769 0.8424 14.69 0.7407 14
  140.1180688 12.1921 ? 140.117973 2.7976 2.64 -0.0061 10
  155.0466054 14.5514 ? 155.046500 2.2058 2.33 0.7091 11
  165.1135983 44.6084 ? 165.113486 1.5504 7.92 0.5604 14
  166.0976054 43.7184 ? 166.097493 1.3907 5.67 0.5297 14
  183.1241447 999.0000 ? 183.124021 0.2840 0.00 1.0000 14
  183.1601890 322.6641 ? 183.160066 0.4532 58.53 0.4593 14
  183.1941591 68.9055 ? 183.194036 2.0798 14.36 0.3626 14
PK$NUM_PEAK: 25
PK$PEAK: m/z int. rel.int.
  69.044635 28.98 28
  71.060367 45.42 45
  72.044349 48.57 48
  85.075953 22.01 22
  87.091593 16.95 16
  97.076061 15.02 15
  98.984109 27.63 27
  112.087028 49.37 49
  113.070937 326.31 326
  113.107207 14.84 14
  115.086605 202.18 202
  123.055438 14.65 14
  124.086953 50.50 50
  125.070925 17.30 17
  127.015408 22.09 22
  138.102553 22.87 22
  139.086662 16.74 16
  140.081864 111.34 111
  140.118069 12.19 12
  155.046605 14.55 14
  165.113598 44.61 44
  166.097605 43.72 43
  183.124145 999.00 999
  183.160189 322.66 322
  183.194159 68.91 68
//
